Malaysia Clinical Lab Market Outlook to 2027F
Medical tourism and Government Investment is driving the future of Healthcare and Clinical Tests in Malaysia
Region:Asia
Author(s):Abhishek Gautam, Sakshi Priya
Product Code:KR1288
December 2022
70
About the Report
The report provides a comprehensive analysis of the potential of the clinical lab market in Malaysia. The report covers an overview and genesis of the industry, market size on the basis of revenue generated.
Its market segmentation includes labs and ownership, region and by test, patient age, mode of test, by payer; growth enablers and drivers, challenges and bottlenecks, trends driving digital adoption; regulatory framework; industry analysis, competitive landscape including competition scenario, and market shares of major players. The report concludes with future market projections of each segmentation and analyst recommendations.
Market Overview:
According to Ken Research estimates Malaysia Clinical Lab Market, – which grew at a CAGR of 10.0% in the period of 2017-2022P – is expected to grow at a CAGR of 13.6% in the forecasted period of 2022P-2027F, owing to growing medical infrastructure, and increasing number of hospitals.
- Robotics testing, the internet of medical things (IMOT) while leveraging 4G/5G facilities & digital pathology to augment pathological diagnosis are some technological innovations in the market.
- Increased adoption of digital pathology has further increased the demand for Clinical Lab services.
Key Trends by Market Segment:
By Type of Labs: Organized labs captures more than half of the market share. High revenue share of organized players is due to the presence of more independent labs, government labs in the market.
By Mode of Test: Doctor referrals comprise most share as patients prefer going through the channel where doctor consultation is the first step because of little or no knowledge of the possible tests required for symptoms. This is the traditional channel of how the healthcare system has worked for decades and still have a major share in the market, however online referrals are on the rise. Online referrals are popularizing due to online consultation being available at the ease as well as since covid-19, most people avoid going to clinics and hospitals except when emergency.
Competitive Landscape
The Malaysia clinical lab market is fragmented with majority independent labs operating in Malaysia. The market share of these independent labs is around 40%. Some of the independent labs operating in Malaysia are Innoquest Pathology, B. P Healthcare, Pathlab etc. The independent players compete with each other on the basis of active locations, no. of tests, best-selling test, USPs etc.
Future Outlook
People have become conscious about health which has led to increase in routine tests and is expected to increase further thereby boosting the clinical lab market in coming years.
Scope of the Report
|
By Type of Lab |
Organised Unorganised |
|
By Type of Ownership |
Private Public |
|
By Mode of Tests |
Walk-Ins Doctor Referrals Corporate Clients Online Referrals External referrals |
|
By Type of Tests |
Routine Esoteric Non-Laboratory |
|
By Patient’s Age |
0-20 20-40 40-60 60 and above |
|
By Region |
West Malaysia East Malaysia |
|
By Payer |
Out of pocket Government Private insurance Corporates |
Products
Key Target Audience – Organizations and Entities Who Can Benefit by Subscribing This Report
- Clinical Lab companies
- Organized Clinical Laboratories
- Unorganized Clinical Laboratories
- Private Hospitals
- Private Equity and Venture Capitalist
- Industry Associations
- Technology providers
- Government Bodies & Regulating Authorities
Time Period Captured in the Report
- Historical Period: 2017-2022P
- Base Year: 2022P
- Forecast Period: 2022P-2027F
Companies
Major Players Mentioned in the Report
Companies Covered:
Diagnostics centers
- BP Leader in Health Check
- Pantai Premier Pathology
- Gribbles
- Lablink Medical Lab
- Clinipath
- Pathlab
- Innoquest
Hospitals
- Sunway Medical Centre
- KPJ healthcare
- Park City medical centre
- Gleneagles Hospital
- PANTAI Hospital
Online Healthcare Apps
- Doctor2U medical Portal
- Bookdoc Connect and Unite
- Doctor Anywhere
- Doc2US
- Docquity
Table of Contents
1. Executive Summary
1.1 Executive summary for Malaysia clinical lab market
2. Country Overview of Malaysia
3. Market Overview & Genesis
3.1. Ecosystem of major entities in Malaysia clinical lab market
3.2. Value chain analysis of clinical lab market
3.3. Malaysian healthcare system
3.4. Market overview of Malaysia healthcare market
3.5. Customer journey in Malaysia clinical lab market
3.6. Cross comparison of clinical laboratories market in Malaysia with south-east Asian countries
4. Market size of Malaysia Clinical Lab FY’2017-FY'2022P
5. Malaysia Clinical Lab Market Segmentation, FY'2022P
5.1. Segmentation by type of labs and by type of ownership
5.2. Segmentation by region and by type of test
5.3. Segmentation by patient age
5.4. Segmentation by mode of test
5.5. Segmentation by payer
6. Industry Analysis
6.1. SWOT analysis of Malaysia clinical lab market
6.2. Trends and development in Malaysia clinical lab market
6.3. Growth driver in Malaysia clinical lab market
6.4. Technological innovation in Malaysia clinical lab market
6.5. Investment scenario in Malaysia clinical lab market
6.6. Issues and challenges in Malaysia clinical lab market
6.7. Government initiatives
7. Impact of Covid-19
7.1. Impact of covid-19 on Malaysia clinical lab market
7.2. Demand of tests during covid-19
7.3. Response to Covid-19 Pandemic
8. Competition Analysis
8.1 Competitive Landscape of Malaysia Clinical Lab Market
8.2 Market Share of Major Players in Malaysia Clinical Lab Market
8.3 Market Positioning of Major Players in Malaysia Clinical Lab Market
8.4 Cross-Comparison of Major Players in Malaysia Clinical Lab Market
8.5 Strength and Weaknesses of Major Players in Malaysia Clinical Labs Market
9. Future Outlook, FY’23F-FY’27F
9.1 Future market size of Malaysia clinical lab market
9.2 Segmentation by type of labs and by type of ownership
9.3 Segmentation by region and by type of test
9.4 Segmentation by patient age
9.5 Segmentation by mode of test
9.6 Segmentation by payer
10. Analyst Recommendation
11. Research Methodology
11.1 Market definitions and assumptions
11.2 Abbreviations
11.3 Market sizing approach
11.4 Consolidated research approach
11.5 Limitations and future conclusion
Disclaimer
Contact Us
Research Methodology
Step 1:
Exhaustive research has been done to identify the list of major players which have a presence in the clinical lab market in Malaysia.
Step 2:
Analysts have conducted desk-based research as well as primary research to understand the value chain, business model, industry trends and collate statistics on industry level information such as purpose of taking payment, company stage, type of booking mode and other areas to create initial level hypothesis. Company level info has also been explored by referring to press release, annual report, financial statement and other documents to understand basic information around the major players.
Step 3 (Market Sizing Approach):
Market Size and CAGR ascertained via primary throughout the study period, interviews with C level executives, Directors and VP, Business Development head to understand value chain, insights and trends of clinical lab market players in Malaysia and growth drivers and challenges faced by clinical lab companies.
Frequently Asked Questions
01 What is the Study Period of this Market Report?
The clinical lab market is covered from 2017–2027F in this report, including a forecast for 2022P-2027F.
02 What are the Key Factors Driving the Clinical Lab Market in Malaysia?
Growing medical infrastructure, increasing number of hospitals and investment in better healthcare services are the factors driving the clinical lab market in Malaysia.
03 Malaysia clinical lab market is consolidated or fragmented?
Malaysia clinical lab market is highly fragmented.
04 Who are the Market Players in the Malaysia clinical lab market?
Major online players are- Innoquest, Pathlab, and Bp healthcare in the Malaysia clinical lab market.
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.